Life Stem Genetics
Life Stem Genetics Inc., a development stage company, focuses on establishing stem cell therapy based clinics worldwide. Its products and services include nutraceutical and medical supplements, and IV nutritional cocktails; stem cell banking services; stem cell treatments for degenerative conditions, hyperbaric oxygen therapy, cancer treatments, and weight loss; anti-aging stem cell therapy; anti… Read more
Life Stem Genetics (LIFS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of April 2014: -0.170x
Based on the latest financial reports, Life Stem Genetics (LIFS) has a cash flow conversion efficiency ratio of -0.170x as of April 2014.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-59.26K) by net assets ($349.15K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Life Stem Genetics - Cash Flow Conversion Efficiency Trend (2012–2013)
This chart illustrates how Life Stem Genetics's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Life Stem Genetics Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Life Stem Genetics ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Green Planet Grp
PINK:GNPG
|
0.322x |
|
IFAN Financial Inc
PINK:IFAN
|
0.025x |
|
Omni Ventures Inc
PINK:OMVE
|
0.399x |
|
InfoSearch Media Inc
PINK:ISHM
|
1.911x |
|
VisionGlobal Corporation
OTCGREY:VIZG
|
-0.178x |
|
Solar Enertech Corp
PINK:SOEN
|
0.065x |
|
BOL Bancshares Inc. PFD
PINK:BOLBP
|
-0.004x |
|
Medical Connections Holdings Inc
OTCGREY:MCTH
|
3.456x |
Annual Cash Flow Conversion Efficiency for Life Stem Genetics (2012–2013)
The table below shows the annual cash flow conversion efficiency of Life Stem Genetics from 2012 to 2013.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2013-07-31 | $-21.54K | $-38.70K | 1.797x | +117.06% |
| 2012-07-31 | $3.67K | $-38.70K | -10.529x | -- |